As the first company worldwide to produce Calcium Levofolinate Pentahydrate (Levoleucovorin Calcium) in commercial quantities, we are committed to delivering the highest product quality. In 1991 we filed the first Drug Master File (DMF) and today our drug substance is approved in Europe, Japan, and the U.S. Our Calcium Levofolinate is produced in dedicated equipment and according to validated production processes.
Calcium Levofolinate Pentahydrate (Levoleucovorin Calcium Pentahydrate), (6S)-5-Formytetrahydrofolic acid, Calcium Salt
We maintain a U.S. DMF, a certificate of Suitability (CEP) and a Common Technical Document (CTD) in Japan. Additional documents such as a Kosher-, non-GMO, or TSE-certificate are also available.